Hyep Ivan

Track

Insider profile

Hyep Ivan's trades of Bicara Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-08-12 2026-08-10
PlS Planned sale
89,237 +19.4%
327.78
US$420,250 		89,237 +19.4% 327.78 US$420,250
2026-08-10 2026-08-10
PrS Proposed sale
56,323
88.58
US$1,777,299 		56,323 88.58 US$1,777,299
2026-07-10 2026-07-08
PlS Planned sale
99,465 -31.0%
222.87
US$629,818 		99,465 -31.0% 222.87 US$629,818
2026-07-10 2026-07-08
PlS Planned sale
4,413 -3.3%
29.82
US$131,616 		4,413 -3.3% 29.82 US$131,616
2026-07-10 2026-07-08
PlS Planned sale
22,757 -14.4%
28.60
US$650,896 		22,757 -14.4% 28.60 US$650,896
2026-07-08 2026-07-08
PrS Proposed sale
28,000
30.25
US$847,000 		28,000 30.25 US$847,000
2026-05-26 2026-05-21
PlS Planned sale
9,200 -6.0%
20.42
US$187,883 		9,200 -6.0% 20.42 US$187,883
2026-05-21 2026-05-21
PrS Proposed sale
9,200
20.42
US$187,883 		9,200 20.42 US$187,883
2026-04-22 2026-04-21
PlS Planned sale
9,200 -6.0%
23.00
US$211,614 		9,200 -6.0% 23.00 US$211,614
2026-04-21 2026-04-21
PrS Proposed sale
9,200
23.18
US$213,210 		9,200 23.18 US$213,210
2026-03-24 2026-03-23
PlS Planned sale
9,200 -6.0%
18.52
US$170,348 		9,200 -6.0% 18.52 US$170,348
2026-03-23 2026-03-23
PrS Proposed sale
9,200
18.60
US$171,120 		9,200 18.60 US$171,120
2026-03-05 2026-03-04
PlS Planned sale
2,963 -2.0%
18.25
US$54,062 		2,963 -2.0% 18.25 US$54,062
2026-03-04 2026-03-04
PrS Proposed sale
2,963
18.25
US$54,062 		2,963 18.25 US$54,062
2026-03-05 2026-03-03
PlS Planned sale
13,555 -8.5%
18.22
US$246,910 		13,555 -8.5% 18.22 US$246,910
2026-03-03 2026-03-03
PrS Proposed sale
13,555
18.22
US$246,910 		13,555 18.22 US$246,910
2026-01-26 2026-01-22
PlS Planned sale
1,882 -1.3%
18.15
US$34,162 		1,882 -1.3% 18.15 US$34,162
2026-01-22 2026-01-22
PrS Proposed sale
1,882
18.15
US$34,158 		1,882 18.15 US$34,158
2025-12-23 2025-12-22
PlS Planned sale
9,200 -6.0%
18.31
US$168,492 		9,200 -6.0% 18.31 US$168,492
2025-12-22 2025-12-22
PrS Proposed sale
9,200
17.87
US$164,404 		9,200 17.87 US$164,404
2025-11-25 2025-11-24
PlS Planned sale
17,795 -10.9%
18.55
US$330,094 		17,795 -10.9% 18.55 US$330,094
2025-11-24 2025-11-24
PrS Proposed sale
17,795
18.55
US$330,094 		17,795 18.55 US$330,094
2025-11-25 2025-11-21
PlS Planned sale
605 -0.4%
18.15
US$10,981 		605 -0.4% 18.15 US$10,981
2025-11-21 2025-11-21
PrS Proposed sale
605
18.15
US$10,981 		605 18.15 US$10,981
2025-10-10 2025-10-09
PlS Planned sale
6,415 -4.2%
18.23
US$116,931 		6,415 -4.2% 18.23 US$116,931
2025-10-09 2025-10-09
PrS Proposed sale
6,415
17.89
US$114,764 		6,415 17.89 US$114,764
2025-10-08 2025-10-08
PrS Proposed sale
5,627
18.17
US$102,242 		5,627 18.17 US$102,242
2025-10-08 2025-10-08
PlS Planned sale
5,627 -3.7%
18.21
US$102,456 		5,627 -3.7% 18.21 US$102,456
2025-10-08 2025-10-07
PlS Planned sale
18,244 -11.2%
18.22
US$332,386 		18,244 -11.2% 18.22 US$332,386
2025-10-07 2025-10-07
PrS Proposed sale
18,244
18.00
US$328,392 		18,244 18.00 US$328,392
2025-10-08 2025-10-06
PlS Planned sale
6,514 -4.3%
18.17
US$118,356 		6,514 -4.3% 18.17 US$118,356
2025-10-06 2025-10-06
PrS Proposed sale
6,514
17.04
US$110,998 		6,514 17.04 US$110,998